Malignant ovarian germ-cell tumours
Malignant ovarian germ-cell tumours account for about 5% of all ovarian malignancies and typically present in the teenage years. They are almost always unilateral and are exquisitely chemosensitive. As such,…
Epithelial ovarian cancer
The incidence of epithelial ovarian cancer in women aged 40 years and younger is 3–17%. The management of these women is challenging and requires balancing the need to treat epithelial…
Borderline ovarian tumours
Borderline ovarian tumours account for 10–20% of all epithelial ovarian cancer. Historically, standard primary surgery has included borderline ovarian tumours, omentectomy, peritoneal washing and multiple biopsies. As one-third of borderline…
Endometrial cancer
Endometrial carcinoma is the most common gynaecological malignancy in the Western world. The standard management of endometrial carcinoma is total hysterectomy and bilateral salpingo-oophorectomy with or without pelvic and para-aortic…
Cervical cancer
Standard treatment for invasive cervical cancer involves either radical surgery or radiotherapy. Childbearing is therefore impossible after either of these treatments. A fertility-sparing option, however, by radical trachelectomy has been…
Vaginal microbicides to prevent human immunodeficiency virus infection in women: Perspectives on the female genital tract, sexual maturity and mucosal inflammation
Topically applied vaginal microbicides to protect against human immunodeficiency (HIV) virus infection offer an important female-controlled prevention strategy. Microbicides have been in development for more than 2 decades, and have…
Overview of microbicides for the prevention of human immunodeficiency virus
Human immunodeficiency virus (HIV) prevention tools that women can use and control are urgently needed. Microbicides are chemical products applied to the vagina or rectum to prevent the sexual transmission…
Fertility Preservation in Gynaecological Cancer – Answers to Multiple Choice Questions for Vol. 26, No. 3
1. a) T b) F c) T d) F e) T Fertility preservation is offered as an option in the management of epithelial ovarian cancer in a woman who has…
Microbicides in Obstetrics and Gynaecology – Multiple Choice Questions for Vol. 26, No. 4
1. Which of the following statement(s) about research and development of microbicides is/are true: a) Microbicides are being developed for women for both vaginal and rectal use. b) Although several…
Future strategies in microbicide development
The reduction in human immunodeficiency virus (HIV) infection in women demonstrated by pericoital use of tenofovir gel has encouraged the continued development of microbicides. Novel approaches include new ways to…
